
The Allstate Corporation (NYSE:ALL – Free Report) – Investment analysts at Zacks Research lifted their Q4 2026 earnings per share (EPS) estimates for shares of Allstate in a report released on Wednesday, February 18th. Zacks Research analyst Team now anticipates that the insurance provider will post earnings per share of $7.57 for the quarter, up from their previous estimate of $7.21. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Allstate’s current full-year earnings is $18.74 per share. Zacks Research also issued estimates for Allstate’s Q3 2027 earnings at $5.14 EPS, Q4 2027 earnings at $7.58 EPS and FY2028 earnings at $16.66 EPS.
Several other equities research analysts have also recently commented on the company. TD Cowen cut Allstate from a “buy” rating to a “hold” rating in a report on Monday, January 12th. Citigroup upped their target price on Allstate from $216.00 to $221.00 and gave the company a “neutral” rating in a report on Tuesday, February 10th. Mizuho lifted their price target on Allstate from $255.00 to $281.00 and gave the stock an “outperform” rating in a report on Monday, February 9th. BMO Capital Markets boosted their price target on shares of Allstate from $235.00 to $244.00 and gave the company an “outperform” rating in a research report on Friday, November 7th. Finally, Wells Fargo & Company cut their price objective on shares of Allstate from $228.00 to $227.00 and set an “equal weight” rating for the company in a research report on Friday. Two analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Allstate currently has an average rating of “Moderate Buy” and a consensus target price of $239.29.
Allstate Stock Up 1.6%
NYSE ALL opened at $206.51 on Friday. Allstate has a one year low of $176.00 and a one year high of $216.75. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.43 and a current ratio of 0.37. The business has a fifty day moving average price of $203.99 and a 200 day moving average price of $204.41. The company has a market cap of $54.04 billion, a P/E ratio of 5.41, a P/E/G ratio of 0.43 and a beta of 0.23.
Allstate (NYSE:ALL – Get Free Report) last released its quarterly earnings results on Wednesday, February 4th. The insurance provider reported $14.31 earnings per share for the quarter, topping analysts’ consensus estimates of $8.72 by $5.59. The company had revenue of $17.35 billion during the quarter, compared to analysts’ expectations of $17.23 billion. Allstate had a return on equity of 39.20% and a net margin of 15.19%.Allstate’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $7.67 EPS.
Institutional Investors Weigh In On Allstate
A number of institutional investors have recently added to or reduced their stakes in the business. Harbor Capital Advisors Inc. grew its position in Allstate by 79.7% during the third quarter. Harbor Capital Advisors Inc. now owns 124 shares of the insurance provider’s stock worth $27,000 after buying an additional 55 shares during the period. Dorato Capital Management purchased a new stake in shares of Allstate during the 4th quarter worth approximately $27,000. Navalign LLC acquired a new stake in shares of Allstate in the 4th quarter worth approximately $27,000. Barnes Dennig Private Wealth Management LLC grew its holdings in shares of Allstate by 112.3% in the 3rd quarter. Barnes Dennig Private Wealth Management LLC now owns 138 shares of the insurance provider’s stock worth $30,000 after acquiring an additional 73 shares during the period. Finally, Clearstead Trust LLC increased its stake in Allstate by 3,800.0% in the 2nd quarter. Clearstead Trust LLC now owns 156 shares of the insurance provider’s stock valued at $31,000 after purchasing an additional 152 shares in the last quarter. Hedge funds and other institutional investors own 76.47% of the company’s stock.
Insider Buying and Selling
In related news, insider Suren Gupta sold 19,593 shares of the firm’s stock in a transaction dated Wednesday, January 7th. The stock was sold at an average price of $210.00, for a total transaction of $4,114,530.00. Following the transaction, the insider owned 100,646 shares of the company’s stock, valued at $21,135,660. This trade represents a 16.30% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. In the last ninety days, insiders have sold 24,729 shares of company stock valued at $5,219,282. 1.70% of the stock is owned by corporate insiders.
Allstate Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be issued a $1.08 dividend. This represents a $4.32 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend is Monday, March 2nd. This is a positive change from Allstate’s previous quarterly dividend of $1.00. Allstate’s dividend payout ratio is presently 10.47%.
Trending Headlines about Allstate
Here are the key news stories impacting Allstate this week:
- Positive Sentiment: Allstate declared roughly $29.3M in preferred dividends for the Jan. 15–Apr. 14 period — a cash-return signal that supports income-focused holders and reinforces the company’s capital distribution profile. Allstate announces preferred dividends payable April 15, 2026
- Positive Sentiment: Allstate is targeting up to $1 billion of limit across Sanders Re III & Sanders Re IV cat bonds — a move that broadens catastrophe risk transfer capacity and may reduce underwriting volatility. Allstate now targets up to $1bn of limit across Sanders Re III & Sanders Re IV cat bonds
- Positive Sentiment: Zacks Research issued several upward revisions to near-term quarter estimates (Q4 2026 and Q3 2027 EPS were raised), indicating some analyst recognition of stronger near-term operating performance. (Zacks summary available via market data reports.)
- Neutral Sentiment: Wells Fargo trimmed its price target slightly from $228 to $227 and keeps an “equal weight” rating — a modest change that still implies roughly ~10% upside from current levels. Analyst price-target note
- Neutral Sentiment: Marketing/promotional item: official rules posted for the 2026 Allstate Women’s Tournament Challenge sweepstakes — immaterial for fundamentals but relevant for brand/marketing visibility. Sweepstakes rules
- Negative Sentiment: Allstate reported estimated January catastrophe losses of $175M ($138M after-tax), primarily from Winter Storm Fern — a near-term hit to underwriting results that can pressure quarterly earnings. January 2026 Monthly Release
- Negative Sentiment: Zacks cut its Q4 2027 EPS estimate (from $8.20 to $7.58) and set FY2028 EPS well below the current consensus — items that suggest some downward pressure on longer-term earnings expectations.
Allstate Company Profile
Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.
The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.
Further Reading
- Five stocks we like better than Allstate
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
